Fresenius Medical Care Files 2024 Annual Report with SEC
I'm PortAI, I can summarize articles.
Fresenius Medical Care (FMS) has filed its 2024 annual report on Form 20-F with the SEC, providing audited financial statements and insights into its operational performance. This filing enhances transparency and regulatory compliance for stakeholders. The company, a leader in renal disease products and services, operates 3,675 dialysis clinics globally, serving 4.2 million patients. FMS is publicly traded on the Frankfurt and New York Stock Exchanges, with a current market cap of $13.7B and a year-to-date price performance of 5.24%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments